作者: Masue Imaizumi
DOI: 10.1007/978-981-10-3886-0_8
关键词:
摘要: Immune thrombocytopenia (ITP), the most common isolated in children, is regarded collectively as various thrombocytopenic diseases commonly involved immunological mechanisms. ITP children can be treated with multiple therapeutic modalities including novel biological agents. However, without available means of confirmative diagnosis yet, more or less requires exclusion diagnosis. As recent investigation inherited disorders has revealed that genetic frequently overlooked, thrombocytopenias (ITs) might become increasingly important differential Misdiagnosis not only prevents IT patients from correct management but also exposes them to inappropriate and potentially harmful treatments. Therefore, based on combined clinical examinations gene analyses may necessary for appropriate treatment choice thrombocytopenia.